An experimental vaccine to prevent chikungunya fever, a viral disease spread by certain species of mosquitoes, is being tested in a clinical trial conducted by National Institute of Allergy and Infectious Diseases (NIAID) scientists at the National Institutes of Health.

Related posts:

1. Priming with DNA vaccine makes avian flu vaccine work better The immune response to an H5N1 avian influenza vaccine was greatly enhanced in healthy adults if they were first primed with a DNA vaccine expressing a gene for a key H5N1 protein, researchers say. Their report describes results from two clinical studies conducted by researchers from the National Institute of Allergy and Infectious Diseases (NIAID), [...]...
2. NIH Scientists Advance Universal Flu Vaccine A universal influenza vaccine — so-called because it could potentially provide protection from all flu strains for decades — may become a reality because of research led by scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health....
3. HIV Vaccine Awareness Day May 18, 2011 Thirty years since the first report of the disease we now know as AIDS, scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, continue advancing toward our goal of a vaccine to prevent HIV infection. I am optimistic that we will succeed....
4. Medicare NIH funds four clinical trials to fight antimicrobial resistance The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced four new contracts for large-scale clinical trials that address the problem of antimicrobial resistance. Over the next five to six years, these new clinical trials will evaluate treatment alternatives for diseases for which antibiotics are prescribed most [...]...
5. NIH remembers Dr. Franklin A. Neva Franklin A. Neva, M.D., a renowned virologist, parasitologist, clinician and former chief of the Laboratory of Parasitic Diseases at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, died on Oct. 15, 2011. He was 89 years old....
6. Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners Men and women infected with HIV reduced the risk of transmitting the virus to their sexual partners by taking oral antiretroviral medicines when their immune systems were relatively healthy, according to findings from a large-scale clinical study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health....
7. NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute [...]...
8. Study Examines Best Time for Healthy HIV-infected People to Begin Antiretrovirals A major new clinical trial seeks to determine whether HIV-infected asymptomatic individuals have less risk of developing AIDS or other serious illness if they begin taking antiretrovirals sooner rather than later, based on their level of CD4+ T-cells. An HIV-infected individual’s level of CD4+ T-cells–commonly referred to as their CD4 count–is a key measure of [...]...
9. MedicareCard.com – Statement of Anthony S. Fauci, M.D., and Daniel Rotrosen, M.D. National Institute of Allergy and Infectious Diseases, National Institutes of Health, on Food Allergy Awareness Week 2010 The National Institute of Allergy and Infectious Diseases (NIAID), the lead institute at the National Institutes of Health for food allergy research, is pleased to commemorate Food Allergy Awareness Week from May 9–15, 2010. First established in 1997 by the Food Allergy and Anaphylaxis Network (FAAN), a patient and family advocacy organization, this week is [...]...
10. Vaccinating Children against Flu Helps Protect Wider Community Results of a clinical trial conducted in a largely self-contained religious community during the 2008-09 influenza season show that immunizing children against seasonal influenza can significantly protect unvaccinated community members against influenza as well. The study was conducted to determine if immunized children could act as a barrier to limit the spread of influenza to the wider, unvaccinated community, a concept known as herd immunity....
11. Medicare Card, NIH Funds 10 International Centers of Excellence for Malaria Research In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world....
12. Clinical trial stopped on combination cholesterol treatment The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, extended-release niacin to statin treatment in people with heart and vascular disease, did not reduce the risk of cardiovascular [...]...
13. Led Team Maps Route for Eliciting HIV Neutralizing Antibodies Researchers have traced in detail how certain powerful HIV neutralizing antibodies evolve, a finding that generates vital clues to guide the design of a preventive HIV vaccine, according to a study appearing in Science Express this week. The discoveries were made by a team led by the Vaccine Research Center (VRC) at the National Institute [...]...
14. Adverse Cardiovascular Events Reported in Testosterone Trial in Older Men A clinical trial of testosterone treatment in older men, reported June 30 online in the New England Journal of Medicine, has found a higher rate of adverse cardiovascular events, such as heart attacks and elevated blood pressure, in a group of older men receiving testosterone gel compared to those receiving placebo. Due to these events, [...]...
15. H1NI? Higher Dose of Seasonal Flu Vaccine Provides Extra Protection Higher Dose of Seasonal Flu Vaccine Provides Extra Protection ...